These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1499106)

  • 1. Heparin adheres to the damaged arterial wall and inhibits its thrombogenicity.
    Araki H; Muramoto J; Nishi K; Jougasaki M; Inoue M
    Circ Res; 1992 Sep; 71(3):577-84. PubMed ID: 1499106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of activated protein C and heparin on thrombotic arterial occlusion in rat mesenteric arteries.
    Araki H; Nishi K; Ishihara N; Okajima K
    Thromb Res; 1991 May; 62(3):209-16. PubMed ID: 1891766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thrombosis on vascular tone in rat mesenteric arteries with endothelium in vivo.
    Araki H; Nishi K; Jougasaki M
    Circ Res; 1990 Aug; 67(2):312-8. PubMed ID: 2376073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition.
    Jang IK; Gold HK; Ziskind AA; Leinbach RC; Fallon JT; Collen D
    Circulation; 1990 Jan; 81(1):219-25. PubMed ID: 2297828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitory effect of activated protein C and heparin on arterial thrombosis].
    Araki H
    Nihon Rinsho; 1992 Feb; 50(2):408-12. PubMed ID: 1613999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of thrombin inhibition in a rat arterial thrombosis model.
    Broersma RJ; Kutcher LW; Heminger EF
    Thromb Res; 1991 Nov; 64(4):405-12. PubMed ID: 1788827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cell matrices modulate smooth muscle cell growth, contractile phenotype and sensitivity to heparin.
    Herman IM
    Haemostasis; 1990; 20 Suppl 1():166-77. PubMed ID: 2083870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentasaccharide and Orgaran arrest, whereas heparin delays thrombus formation in a rat arteriovenous shunt.
    Vogel GM; van Amsterdam RG; Kop WJ; Meuleman DG
    Thromb Haemost; 1993 Jan; 69(1):29-34. PubMed ID: 8446935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombogenicity of the injured vessel wall--role of antithrombin and heparin.
    Frebelius S; Hedin U; Swedenborg J
    Thromb Haemost; 1994 Jan; 71(1):147-53. PubMed ID: 8165634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular smooth muscle cells are responsible for a prothrombotic phenotype of spontaneously hypertensive rat arteries.
    Ait Aissa K; Lagrange J; Mohamadi A; Louis H; Houppert B; Challande P; Wahl D; Lacolley P; Regnault V
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):930-7. PubMed ID: 25722431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells.
    Snow AD; Bolender RP; Wight TN; Clowes AW
    Am J Pathol; 1990 Aug; 137(2):313-30. PubMed ID: 2386199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonfractionated heparin fails to inhibit arterial thrombosis in a human ex vivo thrombosis model.
    Bossavy JP; Cadroy Y; Sakariassen K; Boneu B; Barret A
    Ann Vasc Surg; 1999 Jul; 13(4):393-401. PubMed ID: 10398736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged arterial occlusion caused by thrombus development at sites of arterial bifurcation.
    Araki H; Ishihara N
    Jpn Circ J; 1997 May; 61(5):413-20. PubMed ID: 9192241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin-heparin covalent complex: a possible alternative to heparin for arterial thrombosis prevention.
    Chan AK; Rak J; Berry L; Liao P; Vlasin M; Weitz J; Klement P
    Circulation; 2002 Jul; 106(2):261-5. PubMed ID: 12105168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of platelet-dependent thrombosis by low molecular weight heparin (CY222): comparison with standard heparin.
    Cadroy Y; Harker LA; Hanson SR
    J Lab Clin Med; 1989 Oct; 114(4):349-57. PubMed ID: 2551985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
    Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of thermal exposure on binding of heparin in vitro to the arterial wall and to clot and on the chronic angiographic luminal response to local application of a heparin film during angioplasty in an in vivo rabbit model.
    Spears JR; Yellayi SS; Makkar R; Nallamothu N; Rizvi MA; Sheriff MU; Khetpal V; Zhan H; Jang J; Kundu SK
    Lasers Surg Med; 1994; 14(4):329-46. PubMed ID: 8078383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.